DEAN G. KOLLINTZAS - Corporate Board Profile

GeoVax Labs, Inc.

Filing Date	Source Excerpt
2007-04-30	Dean Kollintzas (2) 2,004 Mr. Kollintzas joined the Board of Directors upon consummation of the merger with GeoVax, Inc. in September 2006. Since 2001 Mr. Kollintzas has been an Intellectual Property Attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions.
2007-08-31	Directors and Executive Officers: Dean G. Kollintzas (5) 440,000 *
2008-04-28	Dean Kollintzas and John Spencer are the members of our Board of Directors who are "independent"... Mr. Kollintzas and Mr. Spencer both serve as the sole members of our Audit and Compensation Committees... The following table sets forth information concerning the compensation earned during the last fiscal year by each individual who served as a director at any time during the fiscal year... Dean Kollintzas 10,750 Fees Earned in Cash, 140,090 Option Awards, Total 150,840.
2009-04-29	Dean G. Kollintzas* 36 Director ... * Member of the Audit Committee and the Compensation Committee of the Board of Directors. ... During fiscal 2008, Mr. Kollintzas, Dr. McNally, Mr. Spencer and Mr. Tsolinas served on the Compensation Committee. ... The following table sets forth information concerning the compensation earned for service on our Board of Directors during the last fiscal year by each individual who served as a director at any time during the fiscal year. ... Dean Kollintzas 10,983 198,464 209,447
2010-03-12	Dean G. Kollintzas is listed as a director and executive officer with beneficial ownership of shares. No specific age, committees, or compensation details are provided.
2010-07-09	Dean G. Kollintzas (1) (2) (3) 37 Director (1) Member of the Compensation Committee of the Board of Directors. (2) Member of the Audit Committee of the Board of Directors. (3) Member of the Nominating and Governance Committee of the Board of Directors. Director Compensation Table
2011-07-06	Dean G. Kollintzas. Mr. Kollintzas joined the Board of Directors upon consummation of the merger with GeoVax, Inc. in September 2006. ... The Board of Directors has concluded that Mr. Kollintzas should serve on the Board of Directors by virtue of his experience with intellectual property matters, biotechnology and pharmaceutical licensing, and FDA regulation.
2012-04-26	Dean G. Kollintzas. Mr. Kollintzas joined the Board of Directors upon consummation of the merger with GeoVax, Inc. in September 2006. ... The Board of Directors has concluded that Mr. Kollintzas should serve on the Board of Directors by virtue of his experience with intellectual property matters, biotechnology and pharmaceutical licensing, and FDA regulation. ... The Board of Directors has determined that Messrs. Antebi, Dodd, Kollintzas, and Spencer are the members of our Board of Directors who are “independent,” ... As independent directors, Messrs. Antebi, Kollintzas and Spencer serve as the members of our Audit Committee, Messrs. Antebi, Dodd and Kollintzas serve as the members of our Compensation Committee, and Messrs. Dodd, Kollintzas and Spencer serve as the members of our Nominating and Governance Committee. ... Director Compensation table shows Dean G. Kollintzas total compensation $46,575.
2013-04-23	Dean G. Kollintzas. Mr. Kollintzas joined the Board of Directors upon consummation of the merger with GeoVax, Inc. in September 2006. ... The Audit Committee is currently comprised of Mr. Spencer (Chairman), Mr. Dodd, and Mr. Kollintzas. ... Our Compensation Committee is currently comprised of Mr. Dodd (Chairman), Mr. Kollintzas, and Mr. Spencer. ... The Nominating and Governance Committee consists of Mr. Spencer (Chairman), Mr. Dodd, and Mr. Kollintzas. ... Director Compensation table shows Dean G. Kollintzas received $29,500 fees earned or paid in cash and $13,875 option awards, total $43,375.
2014-04-30	Dean G. Kollintzas (1)(2)(3) 41 Director... (1) Member of the Compensation Committee of the Board of Directors. (2) Member of the Nominating and Governance Committee of the Board of Directors. (3) Member of the Audit Committee of the Board of Directors... Director Compensation Table: Dean G. Kollintzas Fees Earned or Paid in Cash $28,300, Option Awards $10,775, Total $39,075.
2015-03-31	Dean G. Kollintzas (1)(2)(3) 41 Independent Director... (1) Member of the Compensation Committee... (2) Member of the Nominating and Governance Committee... (3) Member of the Audit Committee... Director Compensation Table: Dean G. Kollintzas Fees Earned or Paid in Cash $28,500, Option Awards $3,400, Total $31,900.
2016-04-29	Dean G. Kollintzas (2)(3) 42 Independent Director... Member of the Nominating and Governance Committee of the Board of Directors... Member of the Audit Committee of the Board of Directors... Director Compensation Table shows Dean G. Kollintzas total compensation $31,148.
2017-04-26	Dean G. Kollintzas (2)(3) 43 Independent Director... Member of the Nominating and Governance Committee of the Board of Directors... Member of the Audit Committee of the Board of Directors... Director Compensation Table... Dean G. Kollintzas 23,800 Fees Earned or Paid in Cash... 4,043 Option Awards... Total 27,843.
2017-06-16	Dean G. Kollintzas is listed as a director in the Security Ownership table with no specific age or committees mentioned.
2018-04-27	Dean G. Kollintzas 44 Independent Director ... Director Compensation table shows Dean G. Kollintzas Fees Earned or Paid in Cash $14,800, Option Awards $6,630, Total $21,430. He is member of Audit Committee and Nominating and Governance Committee.
2019-03-01	Dean G. Kollintzas (6) 274,441 * Includes options to purchase 259,516 shares of Common Stock exercisable within 60 days of February 15, 2019.
2019-12-02	Based solely upon information made available to us, the following table sets forth information with respect to the beneficial ownership of our Common Stock as of November 21, 2019 by (i) each director;... Dean G. Kollintzas (6) 915 * ... Includes options to purchase 885 shares of Common Stock exercisable within 60 days of November 21, 2019.
2020-07-07	Dean G. Kollintzas (1)(2)(3) Member of the Compensation Committee of the Board of Directors. Member of the Nominating and Governance Committee of the Board of Directors. Member of the Audit Committee of the Board of Directors.
2021-06-21	Dean G. Kollintzas Age: 48 Role: Independent Director Gender: male (referred to as Mr. Kollintzas, male pronouns used) Committees: Compensation Committee, Nominating and Governance Committee, Audit Committee Compensation: $54,100 Excerpt: "The following table sets forth information concerning the compensation earned for service on our Board of Directors during the fiscal year ending December 31, 2020 by each individual who served as a director at any time during the fiscal year... Dean G. Kollintzas: Fees Earned or Paid in Cash $26,100, Option Awards $28,000, Total $54,100."
2022-06-13	Dean G. Kollintzas (2)(3) 49 Independent Director (2) Member of the Nominating and Governance Committee of the Board of Directors. (3) Member of the Audit Committee of the Board of Directors. Dean G. Kollintzas Fees Earned or Paid in Cash: $35,975 Option Awards: $71,750 Total: $107,725
2023-06-12	Dean G. Kollintzas (2)(3) Age 50 Independent Director (2) Member of the Nominating and Governance Committee of the Board of Directors. (3) Member of the Audit Committee of the Board of Directors. Director Compensation table: Fees Earned or Paid in Cash $37,500, Option Awards $36,600, Total $74,100.
2024-04-15	Dean G. Kollintzas. Mr. Kollintzas joined the Board of Directors in September 2006. Since 2001 Mr. Kollintzas has been an intellectual property attorney specializing in biotechnology and pharmaceutical licensing, FDA regulation, and corporate/international transactions. ... The Board of Directors has concluded that Mr. Kollintzas should serve on the Board of Directors due to his experience with intellectual property matters, biotechnology and pharmaceutical licensing, and FDA regulation. Board Structure, Leadership, and Committees Our Board of Directors has a standing Audit Committee, Compensation Committee, and Nominating and Governance Committee. ... The Audit Committee is currently comprised of Mr. Spencer (Chairman), Mr. Chase, Mr. Kollintzas, and Ms. Lemerond. ... The Nominating and Governance Committee consists of Dr. McNally (Chairman), Mr. Chase, Mr. Kollintzas, and Dr. Morgan. Director Compensation The following table sets forth information concerning the compensation earned for service on our Board of Directors during the fiscal year ending December 31, 2023 by each individual who served as a director at any time during the fiscal year. Dean G. Kollintzas $37,500 Fees Earned or Paid in Cash, $0 Option Awards, $0 Non-Equity Incentive Plan Compensation, $0 Non-qualified Deferred Compensation Earnings, $0 All Other Compensation, $0 Total $37,500.